Related Experiment Video
Updated: Feb 10, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Is it prime time for personalized medicine in cancer treatment?
Patricia S Kho1,2, Wei Chua1,2, Melissa M Moore1,2
1Sydney Cancer Centre, Concord Repatriation General Hospital, Hospital Road, Concord, NSW 2139, Australia.
Abstract:
Over the last decade, with rapidly advancing biotechnology, the understanding of cancer has changed. The genomic era has resulted in an explosion of targeted therapies and prognostic and predictive biomarkers. This article aims to illustrate the advances made in the practice of oncology as well as the potential and limitations of personalized medicine in cancer.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Microorganisms in Medicine and Therapeutics
Personal Identity
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Self-Report Tests of Personality

